HYPOCHONDROPLASIA
Clinical trials for HYPOCHONDROPLASIA explained in plain language.
Never miss a new study
Get alerted when new HYPOCHONDROPLASIA trials appear
Sign up with your email to follow new studies for HYPOCHONDROPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with rare dwarfism: daily shot may boost growth
Disease control Recruiting nowThis study tests a daily injection called vosoritide in 60 infants and toddlers (0 to 3 years old) with hypochondroplasia, a genetic condition that limits bone growth. The goal is to see if the drug safely improves height and growth rate compared to a placebo over 52 weeks. Parti…
Matched conditions: HYPOCHONDROPLASIA
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Wearable tech tracks movement in bone growth disorders
Knowledge-focused Recruiting nowThis study aims to find out if a wearable device called Syde® can reliably measure limb movement in people with achondroplasia or hypochondroplasia, two conditions that affect bone growth. About 40 participants aged 3 and older who can walk unassisted will wear the device for rec…
Matched conditions: HYPOCHONDROPLASIA
Sponsor: SYSNAV • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC
-
New study tracks growth in kids with rare bone disorder
Knowledge-focused Recruiting nowThis study follows 150 children aged 2.5 to 17 with hypochondroplasia, a condition causing short stature. Researchers will measure height, body proportions, thinking skills, and quality of life over time. No treatment is given; the goal is to learn more about how the condition ch…
Matched conditions: HYPOCHONDROPLASIA
Sponsor: QED Therapeutics, a BridgeBio company • Aim: Knowledge-focused
Last updated May 04, 2026 16:25 UTC